Simple Summary In addition to cancer-related factors, anti-cancer chemotherapy treatment
can drive life-threatening body wasting in a syndrome known as cachexia. Emerging …

Chronic obstructive pulmonary disease (COPD) is one of the most common chronic
diseases in the elderly population and is characterized by persistent respiratory symptoms …

Skeletal muscle atrophy is one of the major side effects of high dose or sustained usage of
glucocorticoids. Pyroptosis is a novel form of pro-inflammatory programmed cell death that …

Cisplatin (DDP) is widely used in cancer treatment, but DDP can cause skeletal muscle
atrophy and cachexia. This study explored the effect and mechanism of daidzein (DAI) in …

Necroptosis, an actively researched form of programmed cell death closely related to the
inflammatory response, is important in a variety of disorders and diseases. However, the …

Both quercetin and leucine have been shown to exert moderately beneficial effects in
preventing muscle atrophy induced by cancers or chemotherapy. However, the combined …

Polygonatum cyrtonema Hua polysaccharide (PCP) is the main bioactive compound derived
from the herb Polygonati Rhizoma, known for its anti-fatigue, antioxidant …

Muscle atrophy is commonly observed during cisplatin chemotherapy, leading to a reduced
QOL in cancer patients. Reduced skeletal muscle mass caused by cisplatin treatment results …

Cancer cachexia-associated muscle wasting as a multifactorial wasting syndrome, is an
important factor affecting the long-term survival rate of tumor patients. Photobiomodulation …

Scope Kaempferol (KMP), a bioactive flavonoid compound found in fruits and vegetables,
contributes to human health in many ways but little is known about its relationship with …